You are working for pharmaceutical company, GenBioform, as program manager for the development of a breakthrough drug to inhibit the growth of cancer tumors and eliminate the need for chemotherapy or radiation treatments. Your CEO is determined that your company will be the first to get approval from the Food and Drug Administration (FDA)for this new drug. You have performed an in-depth analysis of stakeholders in your company and have identified the following key external stakeholders: consumer groups, oncologists, the FDA, and cancer patients. Your next step is to*

1 point

1. Finalize the results of your stakeholder identification and analysis by preparing a transition plan

2. Note stakeholder considerations in your program charter

3. Rank the stakeholders by importance and assign key team members to work with the top two

4. Ask your Marketing Department to perform an analysis of the competition